» Articles » PMID: 35603277

Development and Preliminary Validation of a Machine Learning System for Thyroid Dysfunction Diagnosis Based on Routine Laboratory Tests

Abstract

Background: Approximately 2.4 million patients in Japan would benefit from treatment for thyroid disease, including Graves' disease and Hashimoto's disease. However, only 450,000 of them are receiving treatment, and many patients with thyroid dysfunction remain largely overlooked. In this retrospective study, we aimed to develop and conduct preliminary testing on a machine learning method for screening patients with hyperthyroidism and hypothyroidism who would benefit from prompt medical treatment.

Methods: We collected electronic medical records and medical checkup data from four hospitals in Japan. We applied four machine learning algorithms to construct classification models to distinguish patients with hyperthyroidism and hypothyroidism from control subjects using routine laboratory tests. Performance evaluation metrics such as sensitivity, specificity, and the area under receiver operating characteristic (AUROC) were obtained. Techniques such as feature importance were further applied to understand the contribution of each feature to the machine learning output.

Results: The results of cross-validation and external evaluation indicated that we achieved high classification accuracies (AUROC = 93.8% for hyperthyroidism model and AUROC = 90.9% for hypothyroidism model). Serum creatinine (S-Cr), mean corpuscular volume (MCV), and total cholesterol were the three features that were most strongly correlated with the hyperthyroidism model, and S-Cr, lactic acid dehydrogenase (LDH), and total cholesterol were correlated with the hypothyroidism model.

Conclusions: We demonstrated the potential of machine learning approaches for diagnosing the presence of thyroid dysfunction from routine laboratory tests. Further validation, including prospective clinical studies, is necessary prior to application of our method in the clinic.

Citing Articles

Causal inference and machine learning in endocrine epidemiology.

Inoue K Endocr J. 2024; 71(10):945-953.

PMID: 38972718 PMC: 11778366. DOI: 10.1507/endocrj.EJ24-0193.


Machine Learning Approach with Harmonized Multinational Datasets for Enhanced Prediction of Hypothyroidism in Patients with Type 2 Diabetes.

Adelson R, Garikipati A, Zhou Y, Ciobanu M, Tawara K, Barnes G Diagnostics (Basel). 2024; 14(11).

PMID: 38893680 PMC: 11172278. DOI: 10.3390/diagnostics14111152.


Artificial Intelligence in Thyroidology: A Narrative Review of the Current Applications, Associated Challenges, and Future Directions.

Toro-Tobon D, Loor-Torres R, Duran M, Fan J, Ospina N, Wu Y Thyroid. 2023; 33(8):903-917.

PMID: 37279303 PMC: 10440669. DOI: 10.1089/thy.2023.0132.


An overview of deep learning applications in precocious puberty and thyroid dysfunction.

Razzaq M, Clement F, Yvinec R Front Endocrinol (Lausanne). 2022; 13:959546.

PMID: 36339395 PMC: 9632447. DOI: 10.3389/fendo.2022.959546.

References
1.
Cooper D . Hyperthyroidism. Lancet. 2003; 362(9382):459-68. DOI: 10.1016/S0140-6736(03)14073-1. View

2.
Ngiam K, Khor I . Big data and machine learning algorithms for health-care delivery. Lancet Oncol. 2019; 20(5):e262-e273. DOI: 10.1016/S1470-2045(19)30149-4. View

3.
Youden W . Index for rating diagnostic tests. Cancer. 1950; 3(1):32-5. DOI: 10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3. View

4.
Sato W, Hoshi K, Kawakami J, Sato K, Sugawara A, Saito Y . Assisting the diagnosis of Graves' hyperthyroidism with Bayesian-type and SOM-type neural networks by making use of a set of three routine tests and their correlation with free T4. Biomed Pharmacother. 2009; 64(1):7-15. DOI: 10.1016/j.biopha.2009.02.007. View

5.
Cooper D, KAPLAN M, Ridgway E, Maloof F, Daniels G . Alkaline phosphatase isoenzyme patterns in hyperthyroidism. Ann Intern Med. 1979; 90(2):164-8. DOI: 10.7326/0003-4819-90-2-164. View